Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells.
Cimbora-Zovko
Tamara
T
Ruder Bosković Institute, Zagreb, Croatia. cimbora@irb.hr
Fritz
Gerhard
G
Mikac
Nevenka
N
Osmak
Maja
M
D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000494:pharmacology*; D015536:Down-Regulation; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D020743:rhoB GTP-Binding Protein / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*
D000970:Antineoplastic Agents; D020743:rhoB GTP-Binding Protein; D002945:Cisplatin